Retour
54
22
6
22
Fourchette du Jour
13,40 €
13,67 €
Fourchette 52 Semaines
12,26 €
16,17 €
Volume
1 639 098
Moyenne 50J / 200J
13,97 €
/
14,25 €
Clôture Précédente
13,69 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,2 | 0,3 |
| P/B | 0,0 | 2,9 |
| ROE % | 18,4 | 3,7 |
| Net Margin % | 17,4 | 3,8 |
| Rev Growth 5Y % | 236,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
68,20 €
64,21 € – 77,06 €
|
400 B | 1 |
| FY2027 |
55,78 €
52,94 € – 62,40 €
|
360 B | 2 |
| FY2026 |
61,47 €
59,55 € – 64,35 €
|
350 B | 2 |
Points Clés
Revenue grew 235,95% annually over 5 years — strong growth
ROE of 18,42% — decent returns on equity
Net margin of 17,37% shows strong profitability
Debt/Equity of 0,14 — conservative balance sheet
Generating 12,03B in free cash flow
P/E of 0,20 — trading at a low valuation
Croissance
Revenue Growth (5Y)
235,95%
Revenue (1Y)16,61%
Earnings (1Y)1,54%
FCF Growth (3Y)-45,17%
Qualité
Return on Equity
18,42%
ROIC14,17%
Net Margin17,37%
Op. Margin22,07%
Sécurité
Debt / Equity
0,14
Current Ratio1,92
Interest Coverage25,40
Valorisation
P/E Ratio
0,20
P/B Ratio0,03
EV/EBITDA0,60
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,61% | Revenue Growth (3Y) | 15,06% |
| Earnings Growth (1Y) | 1,54% | Earnings Growth (3Y) | 12,01% |
| Revenue Growth (5Y) | 235,95% | Earnings Growth (5Y) | 295,03% |
| Profitability | |||
| Revenue (TTM) | 325,54B | Net Income (TTM) | 56,54B |
| ROE | 18,42% | ROA | 11,47% |
| Gross Margin | 58,50% | Operating Margin | 22,07% |
| Net Margin | 17,37% | Free Cash Flow (TTM) | 12,03B |
| ROIC | 14,17% | FCF Growth (3Y) | -45,17% |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 1,92 |
| Interest Coverage | 25,40 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 0,20 | P/B Ratio | 0,03 |
| P/S Ratio | 0,03 | PEG Ratio | 10,58 |
| EV/EBITDA | 0,60 | Dividend Yield | 0,01% |
| Market Cap | 11,20B | Enterprise Value | 43,31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 325,54B | 279,16B | 245,88B | 214,39B | 2,56B |
| Net Income | 56,54B | 55,68B | 45,07B | 23,57B | 232,21M |
| EPS (Diluted) | 67,77 | 66,80 | 54,17 | 28,34 | 20,73 |
| Gross Profit | 190,43B | 163,61B | 139,34B | 113,84B | 1,30B |
| Operating Income | 71,84B | 67,73B | 57,14B | 29,48B | 431,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 492,99B | 387,52B | 321,85B | 292,83B | 3,63B |
| Total Liabilities | 155,82B | 106,97B | 90,86B | 102,30B | 1,26B |
| Shareholders' Equity | 333,39B | 280,55B | 230,99B | 190,53B | 2,37B |
| Total Debt | 46,77B | 20,02B | 13,47B | 33,85B | 414,53M |
| Cash & Equivalents | 14,65B | 7,11B | 5,78B | 14,85B | 202,82M |
| Current Assets | 250,11B | 248,05B | 204,25B | 181,86B | 2,03B |
| Current Liabilities | 130,39B | 96,04B | 85,85B | 94,02B | 1,14B |
Scores de Stratégies
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
#223 of 827
#435 of 618
#597 of 670
#435 of 709
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026